AKT1 and neoplasm: The effector kinases in the mTOR pathway activation are AKT, ERK1/2 and ribosomal S6 kinase RSK1, which phosphorylates and inactivates tuberous sclerosis complex 1/2 (a tumour suppressor) and activates mTOR on serine 2448 [55].